Showing results (1-10 of 93) with videos related to

Sort By:
Pageof 10
BMC Medical Ethics|February 26, 2014
Study participants incentives, compensation and reimbursement in resource-constrained settingsTakafira Mduluza, Nicholas Midzi, Donold Duruza, et al.
Malaria Journal|October 10, 2025
Indigenous knowledge systems and malaria prevention in Zimbabwe: a market basket analysisByron Chapoterera, Anesu Marume, Nicholas Midzi, et al.
BMC Medical Ethics|February 26, 2014
Maintaining respect and fairness in the usage of stored shared specimensTakafira Mduluza, Nicholas Midzi, Donold Duruza, et al.
BMC Public Health|November 6, 2023
Religious and traditional beliefs and practices as predictors of mental and physical health outcomes and the role of religious affiliation in health outcomes and risk takingUrsula Wüthrich-Grossenbacher, Nicholas Midzi, Masceline Jenipher Mutsaka-Makuvaza, et al.
Plos One|February 25, 2011
Regulatory and activated T cells in human Schistosoma haematobium infectionsNorman Nausch, Nicholas Midzi, Takafira Mduluza, et al.
Open Forum Infectious Diseases|November 29, 2017
Decrease in Seminal HIV-1 RNA Load After Praziquantel Treatment of Urogenital Schistosomiasis Coinfection in HIV-Positive Men-An Observational StudyNicholas Midzi, Takafira Mduluza, Boniface Mudenge, et al.
Malaria Journal|May 12, 2016
Seroepidemiology of Plasmodium species infections in Zimbabwean populationSeth A Amanfo, Takafira Mduluza, Nicholas Midzi, et al.
BMC Infectious Diseases|November 30, 2007
Cytokine responses to Schistosoma haematobium in a Zimbabwean population: contrasting profiles for IFN-gamma, IL-4, IL-5 and IL-10 with ageFrancisca Mutapi, Georgina Winborn, Nicholas Midzi, et al.
Malawi Medical Journal : the Journal of Medical Association of Malawi|December 24, 2010
Similar cellular responses after treatment with either praziquantel or oxamniquine in Schistosoma mansoni infectionTakafira Mduluza, Francisca Mutapi, Tinashe Ruwona, et al.
Pageof 10